Fig. 4From: SLC39A1 contribute to malignant progression and have clinical prognostic impact in gliomasCorrelation analysis between SLC39A1 expression and clinicopathological parameters using CGGA database. Differential expression of SLC39A1 was significantly related to a Age, b PRS_type, c Grade, d Chemo_status, e IDH mutation status and f 1p19q codeletion status. P < 0.05 indicates a significant differenceBack to article page